These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 24368740

  • 1. Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials.
    Silvetti S, Greco T, Di Prima AL, Mucchetti M, de Lurdes CM, Pasin L, Scandroglio M, Landoni G, Zangrillo A.
    Clin Res Cardiol; 2014 Jul; 103(7):505-13. PubMed ID: 24368740
    [Abstract] [Full Text] [Related]

  • 2. Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.
    Huang X, Lei S, Zhu MF, Jiang RL, Huang LQ, Xia GL, Zhi YH.
    J Zhejiang Univ Sci B; 2013 May; 14(5):400-15. PubMed ID: 23645177
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.
    Silvetti S, Nieminen MS.
    Int J Cardiol; 2016 Jan 01; 202():138-43. PubMed ID: 26386941
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J, Henrich EC, Strobl H, Prondzinsky R, Weiche S, Thiele H, Werdan K, Frantz S, Unverzagt S.
    Cochrane Database Syst Rev; 2018 Jan 29; 1(1):CD009669. PubMed ID: 29376560
    [Abstract] [Full Text] [Related]

  • 10. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
    Cleland JG, Takala A, Apajasalo M, Zethraeus N, Kobelt G.
    Eur J Heart Fail; 2003 Jan 29; 5(1):101-8. PubMed ID: 12559222
    [Abstract] [Full Text] [Related]

  • 11. Repeated Levosimendan Infusions in the Management of Advanced Heart Failure: Review of the Evidence and Meta-analysis of the Effect on Mortality.
    Silvetti S, Pollesello P, Belletti A.
    J Cardiovasc Pharmacol; 2024 Feb 01; 83(2):144-157. PubMed ID: 37991393
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
    Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M, SURVIVE Investigators.
    JAMA; 2007 May 02; 297(17):1883-91. PubMed ID: 17473298
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M, Lehtonen L.
    Curr Pharm Des; 2005 May 02; 11(4):435-55. PubMed ID: 15725064
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
    Moiseyev VS, Põder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI, RUSSLAN Study Investigators.
    Eur Heart J; 2002 Sep 02; 23(18):1422-32. PubMed ID: 12208222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Repetitive infusion of levosimendan in patients with chronic heart failure: a meta-analysis.
    Yi GY, Li JX, Zhang J, Niu LL, Zhang CY.
    Med Sci Monit; 2015 Mar 26; 21():895-901. PubMed ID: 25811545
    [Abstract] [Full Text] [Related]

  • 19. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL, Fitzpatrick JT.
    Ann Pharmacother; 2005 Nov 26; 39(11):1888-96. PubMed ID: 16219899
    [Abstract] [Full Text] [Related]

  • 20. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y.
    Expert Opin Pharmacother; 2007 Apr 26; 8(5):665-77. PubMed ID: 17376021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.